Publication date: Available online 31 October 2015
Source:Vaccine
Author(s): Young-In Kim, Jae-Hyoung Song, Bo-Eun Kwon, Ha-Neul Kim, Min-Duk Seo, KwiSung Park, SangWon Lee, Sang-Gu Yeo, Mi-Na Kweon, Hyun-Jeong Ko, Sun-Young Chang
Enterovirus 71 (EV71) causes hand, foot, and mouth diseases and can result in severe neurological disorders when it infects the central nervous system. Thus, there is a need for the development of effective vaccines against EV71 infection. Here we report that viral capsid protein 1 (VP1), one of the main capsid proteins of EV71, efficiently elicited VP1-specific immunoglobulin G (IgG) in the serum of mice immunized with recombinant VP1. The VP1-specific IgG produced in female mice was efficiently transferred to their offspring, conferring protection against EV71 infection immediately after birth. VP1-specific antibody can neutralize EV71 infection and protect host cells. VP1-specific maternal IgG in offspring was maintained for over 6 months. However, the pre-existence of VP1-specific maternal IgG interfered with the production of VP1-specific IgG antibody secreting cells by active immunization in offspring. Therefore, although our results showed the potential for VP1-specific maternal IgG protection against EV71 in neonatal mice, other strategies must be developed to overcome the hindrance of maternal IgG in active immunization. In this study, we developed an effective and feasible animal model to evaluate the protective efficacy of humoral immunity against EV71 infection using a maternal immunity concept.
from #Medicine via ola Kala on Inoreader http://ift.tt/1HkgvKA
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
2015
(2119)
- ► Δεκεμβρίου (940)
-
▼
Οκτωβρίου
(414)
-
▼
Οκτ 31
(22)
- Influenza vaccine effectiveness against hospitalis...
- A new EV71 VP3 epitope in norovirus P particle vec...
- Pros and cons of VP1-specific maternal IgG for the...
- Differences in efficiency, satisfaction and advers...
- Pertussis vaccination during pregnancy in Vietnam:...
- PneuMum: Impact from a randomised controlled trial...
- Translating Research to Practice for Children With...
- Testing anti-HIV activity of antiretroviral agents...
- Risk of congenital cytomegalovirus infection among...
- Susceptibility of HPV16 and 18 to high level disin...
- Increased expression and dysregulated association ...
- Human papillomavirus infection in male patients wi...
- Hydrolyzed fish proteins reduced activation of cas...
- Contaminant release history identification in 2-D ...
- Medicine,New Articles,October 31st,2015
- Synthesis and comparison of the biological activit...
- 1,2,3-Triazole pharmacophore-based benzofused nitr...
- Discovery of bis-ary urea derivatives as potent an...
- Synthesis of di- and tri-saccharide fragments of S...
- Investigation of the mechanisms of Angelica dahuri...
- Retrospective case-series of Paecilomyces lilacinu...
- Meningitis caused by Pasteurella multocida in a do...
-
▼
Οκτ 31
(22)
Αναζήτηση αυτού του ιστολογίου
Σάββατο 31 Οκτωβρίου 2015
Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.